MicroRNA Profile Predicts Recurrence after Resection in Patients with Hepatocellular Carcinoma
Author Information
Author(s): Fumiaki Sato, Etsuro Hatano, Koji Kitamura, Akira Myomoto, Takeshi Fujiwara, Satoko Takizawa, Soken Tsuchiya, Gozoh Tsujimoto, Shinji Uemoto, Kazuharu Shimizu
Primary Institution: Kyoto University
Hypothesis
Can microRNA expression profiling predict the risk of recurrence in hepatocellular carcinoma patients after liver resection?
Conclusion
MicroRNA profiling can predict HCC recurrence in Milan criteria cases.
Supporting Evidence
- The number of recurrence-related microRNAs was significantly larger in non-tumor tissues than in tumor tissues.
- The best prediction model achieved a time-averaged AUROC of 0.8281.
- The recurrence-free survival curve of the low-risk group was significantly better than that of the high-risk group.
Takeaway
Doctors can use tiny molecules called microRNAs to help figure out if liver cancer will come back after surgery.
Methodology
MicroRNA expression profiling was performed on paired tumor and non-tumor liver tissues from 73 HCC patients, and prediction models were constructed using Cox proportional hazard models and principal component analysis.
Limitations
The study was only internally validated and requires external validation before clinical application.
Participant Demographics
Patients were HCC patients who satisfied the Milan Criteria and had Child-Pugh A-B level cirrhosis.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website